These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31680850)

  • 1. CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease.
    Karami A; Eriksdotter M; Kadir A; Almkvist O; Nordberg A; Darreh-Shori T
    Front Mol Neurosci; 2019; 12():239. PubMed ID: 31680850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment.
    Karami A; Darreh-Shori T; Schultzberg M; Eriksdotter M
    Front Aging Neurosci; 2021; 13():704583. PubMed ID: 34512307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine.
    Darreh-Shori T; Kadir A; Almkvist O; Grut M; Wall A; Blomquist G; Eriksson B; Långström B; Nordberg A
    Neurobiol Aging; 2008 Feb; 29(2):168-84. PubMed ID: 17196712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD.
    Kadir A; Darreh-Shori T; Almkvist O; Wall A; Grut M; Strandberg B; Ringheim A; B Eriksson ; Blomquist G; Långström B; Nordberg A
    Neurobiol Aging; 2008 Aug; 29(8):1204-17. PubMed ID: 17379359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months.
    Blesa R; Davidson M; Kurz A; Reichman W; van Baelen B; Schwalen S
    Dement Geriatr Cogn Disord; 2003; 15(2):79-87. PubMed ID: 12566596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (4):CD001747. PubMed ID: 11687119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.
    Moss DE; Perez RG
    Curr Alzheimer Res; 2021; 18(13):1010-1022. PubMed ID: 34911424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid cholinergic biomarkers are associated with postoperative delirium in elderly patients undergoing Total hip/knee replacement: a prospective cohort study.
    Lin X; Tang J; Liu C; Li X; Cao X; Wang B; Dong R; Xu W; Yu X; Wang M; Bi Y
    BMC Anesthesiol; 2020 Sep; 20(1):246. PubMed ID: 32988381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.
    Vijayaraghavan S; Karami A; Aeinehband S; Behbahani H; Grandien A; Nilsson B; Ekdahl KN; Lindblom RP; Piehl F; Darreh-Shori T
    PLoS One; 2013; 8(6):e65936. PubMed ID: 23840379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2002; (3):CD001747. PubMed ID: 12137632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine: a review of its use in Alzheimer's disease.
    Scott LJ; Goa KL
    Drugs; 2000 Nov; 60(5):1095-122. PubMed ID: 11129124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
    Karami A; Eyjolfsdottir H; Vijayaraghavan S; Lind G; Almqvist P; Kadir A; Linderoth B; Andreasen N; Blennow K; Wall A; Westman E; Ferreira D; Kristoffersen Wiberg M; Wahlund LO; Seiger Å; Nordberg A; Wahlberg L; Darreh-Shori T; Eriksdotter M
    Alzheimers Dement; 2015 Nov; 11(11):1316-28. PubMed ID: 25676388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintaining cognitive function in Alzheimer disease: how effective are current treatments?
    Tariot PN
    Alzheimer Dis Assoc Disord; 2001 Aug; 15 Suppl 1():S26-33. PubMed ID: 11669506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats.
    Tomassoni D; Catalani A; Cinque C; Di Tullio MA; Tayebati SK; Cadoni A; Nwankwo IE; Traini E; Amenta F
    Curr Alzheimer Res; 2012 Jan; 9(1):120-7. PubMed ID: 22191561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.
    Kadir A; Darreh-Shori T; Almkvist O; Wall A; Långström B; Nordberg A
    Psychopharmacology (Berl); 2007 May; 191(4):1005-14. PubMed ID: 17310387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (1):CD001747. PubMed ID: 11279727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
    Parnetti L; Amici S; Lanari A; Romani C; Antognelli C; Andreasen N; Minthon L; Davidsson P; Pottel H; Blennow K; Gallai V
    Neurol Sci; 2002 Sep; 23 Suppl 2():S95-6. PubMed ID: 12548360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease.
    Maelicke A
    Dement Geriatr Cogn Disord; 2000 Sep; 11 Suppl 1():11-8. PubMed ID: 10971047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revealing the cholinergic inhibition mechanism of Alzheimer's by galantamine: a metadynamics simulation study.
    Ghosh S; Jana K; Wakchaure PD; Ganguly B
    J Biomol Struct Dyn; 2022 Jul; 40(11):5100-5111. PubMed ID: 33382027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterases: new roles in brain function and in Alzheimer's disease.
    Giacobini E
    Neurochem Res; 2003 Apr; 28(3-4):515-22. PubMed ID: 12675140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.